2 completed, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow GSK2245035: new trials by email Literature Review of GSK2245035 trials Research Report on GSK2245035
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma GSK2245035, Placebo, FP-DPI - Asthma | Phase 2 | Withdrawn | GlaxoSmithKline | 2019-01-21 | 2018-10-16 | |
| To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies GSK2245035, Placebo - Mild Asthma and Allergic Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 42 | 2013-03-01 | 2014-10-20 |
| A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies GSK2245035, Type 1 amber glass bottle, Placebo - Asthma and Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 18 | 2012-04-01 | 2017-01-30 |
Asthma (2) · Rhinitis, Allergic (2) · Rhinitis (1)
GlaxoSmithKline (3)
Canada (2)